Literature DB >> 346276

A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.

M J Garrett, H J Hughes, L S Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 346276

Source DB:  PubMed          Journal:  Clin Oncol        ISSN： 0305-7399


× No keyword cloud information.
  10 in total

1.  Pre-radiation chemotherapy in glioma patients with poor prognostic factors.

Authors:  K Watne; O Nome; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

3.  Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.

Authors:  J C Tonn; R Schönmayr; H P Kraemer
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

4.  Measurements of the volume and density of intracerebral tumors by CT following therapy.

Authors:  K Kretzschmar; K H Schicketanz
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

Review 5.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

6.  Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party.

Authors: 
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

7.  Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.

Authors:  Michael A Badruddoja; Kara Penne; Annick Desjardins; David A Reardon; Jeremy N Rich; Jennifer A Quinn; Sith Sathornsumetee; Allan H Friedman; Darell D Bigner; James E Herndon; Ann Cahill; Henry S Friedman; James J Vredenburgh
Journal:  Neuro Oncol       Date:  2006-11-15       Impact factor: 12.300

Review 8.  The basis for current treatment recommendations for malignant gliomas.

Authors:  H A Fine
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.

Authors:  S P Stenning; L S Freedman; N M Bleehen
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

10.  A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.

Authors:  N M Bleehen; C R Wiltshire; P N Plowman; J V Watson; J R Gleave; A E Holmes; W S Lewin; C S Treip; T D Hawkins
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.